Drew Schiff

Track

Insider profile

Currently holds a position at Aclaris Therapeutics Inc

Positions

Position Company Period
Independent Director Aclaris Therapeutics Inc Aug. 9, 2017 -
Independent Director ZELTIQ Aesthetics Inc July 1, 2010 - April 28, 2017
Independent Director Agile Therapeutics Inc July 1, 2012 - Feb. 24, 2016
Drew Schiff's trades of Aclaris Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-11-14 2022-11-14
PlS Planned sale
89,347 -44.7%
247.00
US$1,388,573 		89,347 -44.7% 247.00 US$1,388,573
2022-11-14 2022-11-11
PlS Planned sale
9,673 +26.4%
12.65
US$58,856 		9,673 +26.4% 12.65 US$58,856
2022-11-14 2022-11-10
PlS Planned sale
28,464 +48.1%
219.96
US$3,972,538 		28,464 +48.1% 219.96 US$3,972,538
2022-10-26 2022-10-26
PlS Planned sale
14,540 -2.9%
17.01
US$247,253 		14,540 -2.9% 17.01 US$247,253
2022-10-26 2022-10-25
PlS Planned sale
12,018 -2.3%
17.02
US$204,516 		12,018 -2.3% 17.02 US$204,516
2022-10-26 2022-10-24
PlS Planned sale
14,616 -2.8%
17.01
US$248,586 		14,616 -2.8% 17.01 US$248,586
2022-10-19 2022-10-18
PlS Planned sale
32,093 -5.7%
16.89
US$542,022 		32,093 -5.7% 16.89 US$542,022
2022-10-19 2022-10-17
PlS Planned sale
19,944 -3.4%
16.05
US$320,087 		19,944 -3.4% 16.05 US$320,087
2022-10-11 2022-10-07
PlS Planned sale
7,324 -1.2%
16.16
US$118,349 		7,324 -1.2% 16.16 US$118,349
2022-10-06 2022-10-06
PlS Planned sale
37,839 -6.0%
16.54
US$625,744 		37,839 -6.0% 16.54 US$625,744
2022-10-06 2022-10-04
PlS Planned sale
7,700 -1.2%
16.01
US$123,259 		7,700 -1.2% 16.01 US$123,259
2022-06-21 2022-06-17
PlS Planned sale
19,565 -100.0%
15.14
US$296,269 		19,565 -100.0% 15.14 US$296,269